Guangtong Pharmaceutical (300966.SZ): Net loss of 5.1186 million yuan in the first half of the year, turning from profit to loss compared to the same period last year.

Gelonghui Finance · Aug 27, 2024 20:53

Gelonghui announced its semi-annual report for 2024, with revenue for the reporting period at 0.234 billion yuan, a decrease of 12.69% compared to the previous year; the net income attributable to shareholders of the listed company was -5.1186 million yuan, with a year-on-year loss; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -4.9268 million yuan; and the basic earnings per share was -0.04 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

共同药业(300966.SZ)：上半年净亏损511.86万元 同比盈转亏

Guangtong Pharmaceutical (300966.SZ): Net loss of 5.1186 million yuan in the first half of the year, turning from profit to loss compared to the same period last year.

Risk Disclaimer

Statement

共同药业(300966.SZ)：上半年净亏损511.86万元同比盈转亏